AppointmentsNew Medical Director Appointed At UK Cannabis Company AltoVerde

New Medical Director Appointed At UK Cannabis Company AltoVerde

-

MULTIFACETED cannabis company AltoVerde has announced the appointment of Dr Kuldip Birdi as its new Medical Director. 

Dr Kuldip Birdi will help develop AltoVerde’s medical cannabis programmes as it expands from its UK base into Europe.

Dr Birdi has a distinguished career with over 15 years working for both the NHS and the pharmaceutical industry, and is now working to fully unlock the potential of the cannabis plant in partnership with AltoVerde.

Dr Kuldip Birdi

Mitesh Makwana, Founder and Chairman of AltoVerde, said: “The key to unlocking the true potential of medical cannabis is through strong partnerships with the pharmaceutical industry. 

“Only through such means will the pharma truly understand the benefits of cannabis based medicinal products, and the cannabis industry be able to formulate medicinal products in accordance with the country regulations.

“Dr Birdi, with his experience in both sectors is ideally suited for this role, and we look forward to working with him towards bringing greater acceptance of medicinal cannabis products both to the public and the medical sector itself”.

Dr Birdi said: “AltoVerde’s ethos is inspiring. When I was first introduced to the company, I realised immediately how AltoVerde was setting itself apart from its competitors and how unique it would become. 

“I am a true believer in the patient-centred approach to management with medical cannabis which is what the company aims to do. I am excited to be part of the business at this stage and of something which will no doubt grow and shape the medical cannabis industry”.

Peter
Peter
Peter McCusker is an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant.

Latest news

MGC Pharmaceuticals Releases Update On CimetrA Clinical Trial Progress In USA

MGC Pharmaceuticals Ltd (ASX, LSE: MXC, ‘MGC Pharma’ or ‘the Company’), a European based bio-pharma company specialising in the production and development...

European Cannabis Stocks Review: Akanda’s ‘Concerned Shareholders’ Oust All Directors Except CEO To Prevent ‘Potentially Irreparable Harm’ – More From Goodbody Health & Chill...

It has been another week of positive developments for the cannabis industry across Europe, with yet more markets making...

Analysis Shows UK Market Could Grow To Over £1bn By 2026 As London Prepares To Host Europe’s Leading Cannabis Conference

ANALYSIS shows UK market could grow to over £1bn by 2026 as London prepares to host Europe’s leading cannabis...

Medical Cannabis Could Be Available In Spain By The End Of The Year

SPAIN could now see the regulation and distribution of medical cannabis rolled out before the end of the year...

New UK Company Heralds Its ‘Unique’ Medical Cannabis Delivery Mechanism

CANNABIS extraction and formulations specialist 113 Botanicals is in the process of securing Good manufacturing Practice (GMP) compliance for...

German Cannabis Bill By Year End With Adult-Use Launch Likely In Early 2024

GERMANY’s draft cannabis law should be ready by the end of the year with the launch of its adult-use...

Must read

You might also likeRELATED
Recommended to you